SEARCH

SEARCH BY CITATION

References

  • Bjarnason, I., MacPherson, A. & Hollander, D. (1995) Intestinal permeability: an overview. Gastroenterology, 108, 15661581.
  • Blijlevens, N.M.A., Donnelly, J.P. & De Pauw, B.E. (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplantation, 25, 12691278.
  • Bow, E.J., Loewen, R., Cheang, M.S., Shore, T.B., Rubinger, M. & Schacter, B. (1997) Cytotoxic therapy-induced d-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults. Journal of Clinical Oncology, 15, 22542261.
  • Bow, E.J., Gallant, G., Williams, G.J., Woloschuk, D., Shore, T.B., Rubinger, M. & Schacter, B.A. (1998) Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin. Cancer, 83, 13441354.
  • Callum, J.L., Brandwein, J.M., Sutcliffe, S.B., Scott, J.G. & Keating, A. (1991) Influence of total body irradiation on infections after autologous bone marrow transplantation. Bone Marrow Transplantation, 8, 245251.
  • Daenen, S., Muskiet, F.A.J., Marrink, J. & Halie, M.R. (1991) Aggressive chemotherapy for acute leukaemia frequently causes intestinal protein leakage. European Journal of Cancer, 27, 552556.
  • Epstein, J.B., Pearsall, N.N. & Treulove, E.L. (1980) Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. Journal of Clinical Microbiology, 12, 475476.
  • Fegan, C., Poynton, C.H. & Whittaker, J.A. (1990) The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplantation, 5, 373377.
  • Girmenia, C., Micozzi, A., Cartoni, C., De-Bernardis, F., Cassone, A. & Martino, P. (1999) Detection of Candida mannoproteinemia in patients with neutropenic enterocolitis. European Journal of Clinical and Microbiological Infectious Diseases, 18, 5558.
  • Gomez, L., Martino, R. & Rolston, K.V. (1998) Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases. Clinical Infectious Diseases, 27, 695699.
  • Goodman, J.L., Winston, D.J., Greenfield, R.A., Chandrasekar, P.H., Fox, B., Kaizer, H., Shadduck, R.K., Shea, T.C., Stiff, P., Friedman, D.J., Powderly, W.G., Silber, J.L., Horowitz, H., Lichtin, A., Wolff, S.N., Mangan, K.F., Silver, S.M., Weisdorf, D., Ho, W.G., Gilbert, G. & Buell, D. (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine, 326, 845851.
  • Goodrich, J.M., Reed, E.C., Mori, M., Fisher, L.D., Skerrett, S., Dandliker, P.S., Klis, B., Counts, G.W. & Meyers, J.D. (1991) Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. Journal of Infectious Diseases, 164, 731740.
  • Gotzsche, P.C. & Johansen, H.K. (1997) Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. British Medical Journal, 314, 1244.
  • Guiot, H.F.I., Fibbe, W.E. & Van't Wout, J.W. (1994) Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clinical Infectious Diseases, 18, 525532.
  • Jarvis, W.R. & Martone, W.J. (1992) Predominant pathogens in hospital infections. Journal of Antimicrobial Chemotherapy, 29, 1924.
  • Johansson, J.E. & Ekman, T. (1997) Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings. Bone Marrow Transplantation, 19, 921925.
  • Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., Kami, M., Akiyama, H., Hirai, H. & Togawa, A. (2000) Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. Cancer, 89, 16111625.DOI: 10.1002/1097-0142(20001001)89:7<1611::AID-CNCR27>3.0.CO;2-B
  • Katz, J.A., Wagner, M.L., Gresik, M.V., Mahoney, D.H. & Fernbach, D.J. (1990) Typhlitis: an 18-year experience and postmortem review. Cancer, 65, 10411047.
  • Keefe, D.M., Cummins, A.G., Dale, B.M., Kotasek, D., Robb, T.A. & Sage, R.E. (1997) Effect of high-dose chemotherapy on intestinal permeability in humans. Clinical Science, 92, 385389.
  • Keefe, D.M.K., Brealey, J., Goland, G.J. & Cummins, A.G. (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut, 47, 632637.
  • Laverdiere, M., Rotstein, C., Bow, E., Roberts, R.S., Ioannou, S., Carr, D., Moghaddam, N. & the Canadian Fluconazole Study Group (2000) Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. Journal of Antimicrobial Chemotherapy, 46, 10011008.DOI: 10.1093/jac/46.6.1001
  • Martino, P., Girmenia, C., Venditti, M., Micozzi, A., Santilli, S., Burgio, V.L. & Mandelli, F. (1989) Candida colonization and systemic infection in neutropenic patients. Cancer, 64, 20302034.
  • Mehentee, J.F. & Hay, R.J. (1989) In vitro adherence of candida albicans strains to murine gastrointestinal mucosa cells and explants and the role of environmental pH. Journal of General Microbiology, 135, 21812188.
  • Michallet, M., Persat, F., Kranszhofer, N., Levron, J.-C., Prat, C., Belhabri, A., Chwetzoff, E., Le Moing, J.-P., Fiere, D. & Piens, M.-A. (1998) Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation. Bone Marrow Transplantation, 21, 12391243.
  • Micozzi, A., Cartoni, C., Monaco, M., Martino, P., Zittoun, R. & Mandelli, F. (1996) High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission. Supportive Care in Cancer, 4, 294297.
  • Odds, F.C. (1987) Candida infections: an overview. CRC Critical Reviews in Microbiology, 15, 15.
  • Parrilli, G., Iaffaioli, R.V., Capuano, G., Budillon, G. & Bianco, A.R. (1982) Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy. Cancer Treatment Reports, 66, 14351436.
  • Parrilli, G., Iaffaioli, R.V., Martorano, M., Cuomo, R., Tafuto, S., Zampino, M.G., Budillon, G. & Bianco, A.R. (1989) Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Research, 49, 36893691.
  • Pledger, J.V., Pearson, A.D., Craft, A.W., Laker, M.F. & Eastham, E.J. (1988) Intestinal permeability during chemotherapy for childhood tumours. European Journal of Pediatrics, 147, 123127.
  • Prentice, A.G. & Donnelly, J.P. (2001) Oral antifungals as prophylaxis in haematological malignancy. Blood Reviews, 15, 18.DOI: 10.1054/blre.2001.0145
  • Prentice, H.G., Kibbler, C.C. & Prentice, A.G. (2000) Towards a targeted, risk-based, antifungal strategy in neutropenic patients. British Journal of Haematology, 110, 273284.DOI: 10.1046/j.1365-2141.2000.02014.x
  • Rapoport, A.P., Miller Watelet, L.F., Linder, T., Rberly, S., Raubertas, R.F., Lipp, J., Duerst, R., Abboud, C.N., Constine, L., Andrews, J., Etter, M.A., Spear, L., Powley, E., Packman, C.H., Rowe, J.M., Schwertschlag, U., Bedrosian, C. & Liesveld, J.I. (1999) Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. Journal of Clinical Oncology, 17, 24462453.
  • Rex, J.H., Walsh, T.J., Sobel, J.D., Filler, S.G., Pappas, P.G., Dismukes, W.E. & Edwards, J.E. (2000) Practice guidelines for the treatment of candidiasis. Clinical Infectious Diseases, 30, 662678.
  • Rex, J.H., Walsh, T.J., Nettleman, M., Anaissie, E.J., Bennett, J.E., Bow, E., Carillo-Munoz, A.J., Chavanet, P., Cloud, G.A., Denning, D.W., DePauw, B.E., Edwards, J.E.J., Hiemenz, J.W., Kauffman, C.A., Lopez-Berestein, G., Martino, P., Sobel, J.D., Stevens, D.A., Sylvester, R., Tollemar, J., Viscoli, C., Viviani, M.A. & Wu, T. (2001) Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clinical Infectious Diseases, 33, 95106.
  • Rotstein, C., Bow, E., Laverdiere, M., Ioannou, S., Carr, D., Moghaddam, N. & the Canadian Fluconazole Study Group (1999) Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. Clinical Infectious Diseases, 28, 340.
  • Samonis, G., Gikas, A., Anaissie, E.J., Vrenzos, G., Maraki, S., Tselentis, Y. & Bodey, G.P. (1993) Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrobial Agents and Chemotherapy, 37, 5153.
  • Sandford, G.R., Merz, W.G., Wingard, J.R., Charache, P. & Saral, R. (1980) The value of fungal surveillance cultures as predictors of systemic fungal infections. Journal of Infectious Diseases, 142, 503509.
  • Sandovsky-Losica, H. & Segal, E. (1989) Interaction of Candida albicans with murine gastrointestinal mucosa: effect of irradiation on adherence in vitro. Journal of Medical and Veterinary Mycology, 27, 345352.
  • Sandovsky-Losica, H. & Segal, E. (1990) Interaction of Candida albicans with murine gastrointestinal mucosa from methotrexate and 5-fluorouracil treated animals: in vitro adhesion and prevention. Journal of Medical and Veterinary Mycology, 28, 279287.
  • Sandovsky-Losica, H., Barr-Nea, L. & Segal, E. (1992) Fatal systemic candidiasis of gastrointestinal origin: an experimental model in mice compromised by anti-cancer treatment. Journal of Medical and Veterinary Mycology, 30, 219231.
  • Seipelt, G., Hofmann, W.-K., Martin, H., Wassmann, B., Boehme, A., Ottmann, O.G. & Hoelzer, D. (1998) Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin. Annals of Hematology, 76, 145151.DOI: 10.1007/s002770050379
  • Selby, P., McElwain, T.J., Crofts, M., Lopes, N. & Mundy, J. (1984) 51Cr-EDTA test for intestinal permeability. Lancet, 2, 3839.
  • Slavin, M.A., Osborne, B., Adams, R., Levenstein, M.J., Schoch, H.G., Feldman, A.R., Meyers, J.D. & Bowden, R.A. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation – a prospective, randomized, double-blind study. Journal of Infectious Disease, 171, 15451552.
  • Sonis, S.T. (1998) Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology, 34, 3943.
  • Uzun, O., Ascioglu, S., Anaissie, E.J. & Rex, J.H. (2001) Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clinical Infectious Diseases, 32, 17131717.DOI: 10.1086/320757
  • Verfaillie, C., Weisdorf, D., Haake, R., Hostetter, M., Ramsay, N.K.C. & McGlave, P. (1991) Candida infections in bone marrow transplant recipients. Bone Marrow Transplantation, 8, 177184.
  • Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., DePauw, B., Meunier, F. & the Invasive Fungal Infection Group of the EORTC (1999) Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clinical Infectious Diseases, 28, 10711079.
  • Viscoli, C., Paesmans, M., Sanz, M., Castagnola, E., Klastersky, J., Martino, P. & Glauser, M. on behalf of the International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer (2001) Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. Clinical Infectious Diseases, 32, 15321537.
  • Vlasveld, L.T.H., Zwaan, F.E., Fibbe, W.E., Tham, R.T.O., Tjon, A., Kluin, P.M. & Willemze, R. (1991) Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies. Annals of Hematology, 62, 129134.
  • Wardley, A.M., Jayson, G.C., Swindell, R., Morgenstern, G.R., Chang, J., Bloor, R., Fraser, C.J. & Scarffe, J.H. (2000) Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue. British Journal of Haematology, 110, 299.
  • Wiesner, S.M., Jechorek, R.P., Garni, R.M., Bendel, C.M. & Wells, C.L. (2001) Gastrointestinal colonization by Candida albicans mutant strains in antibiotic-treated mice. Clinical and Diagnostic Laboratory Immunology, 8, 192195.DOI: 10.1128/CDLI.8.1.192-195.2001
  • Xun, C.Q., Thompson, J.S., Jennings, C.D., Brown, S.A. & Widmer, M.B. (1994) Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood, 83, 23602367.